--- !oddb.org,2003/ODDB::CyP450SubstrateConnection 
oid: 705
cyp450: &id002 !oddb.org,2003/ODDB::CyP450 
  cyp_id: 2D6
  inhibitors: 
    chlorpheniramine: !oddb.org,2003/ODDB::CyP450InhibitorConnection 
      oid: 81
      cyp450: *id002
      category: ""
      links: []

      substance: &id001 !oddb.org,2003/ODDB::Substance 
        oid: 6361
        descriptions: !oddb.org,2003/ODDB::SimpleLanguage::Descriptions 
          fr: "Chlorph\xE9namine"
          de: Chlorphenamin
          lt: Chlorphenaminum
          en: Chlorphenamine
        synonyms: 
        - Chlorpheniraminum
        - Chlorpheniramin
        - Chlorpheniramine
        - "Chlorph\xE9niramine"
        effective_form: *id001
        swissmedic_code: 
      auc_factor: "1"
    sertindolum: !oddb.org,2003/ODDB::CyP450InhibitorConnection 
      oid: 104
      cyp450: *id002
      category: 
      links: []

      substance: &id003 !oddb.org,2003/ODDB::Substance 
        oid: 5953
        descriptions: !oddb.org,2003/ODDB::SimpleLanguage::Descriptions 
          de: Sertindol
          lt: Sertindolum
          en: Sertindole
        synonyms: []

        effective_form: *id003
        swissmedic_code: 
      auc_factor: 
    ritonavirum: !oddb.org,2003/ODDB::CyP450InhibitorConnection 
      oid: 103
      cyp450: *id002
      category: ""
      links: 
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8613951&dopt=Abstract
        text: J Pharmacol Exp Ther 1996;277(1):423-431
      substance: &id004 !oddb.org,2003/ODDB::Substance 
        oid: 5851
        descriptions: !oddb.org,2003/ODDB::SimpleLanguage::Descriptions 
          lt: Ritonavirum
          en: Ritonavir
        synonyms: []

        effective_form: *id004
        swissmedic_code: 
      auc_factor: "1"
    paroxetinum: !oddb.org,2003/ODDB::CyP450InhibitorConnection 
      oid: 98
      cyp450: *id002
      category: ""
      links: 
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: "Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine."
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12584155&dopt=Abstract
        text: Drug Metab Dispos. 2003 Mar;31(3):289-93.
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15632378&dopt=Abstract
        text: J Natl Cancer Inst. 2005 Jan 5;97(1):30-9.
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14652237&dopt=Abstract
        text: J Natl Cancer Inst. 2003 Dec 3;95(23):1758-64.
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine.
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8513845&dopt=Abstract
        text: Eur J Clin Pharmacol 44:349-355, 1993.
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline.
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11147928&dopt=Abstract
        text: Pharmacopsychiatry. 2000 Nov;33(6):213-7.
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: "CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6."
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12173784&dopt=Abstract
        text: Pharmacotherapy. 2002 Aug;22(8):1001-6.
      substance: &id005 !oddb.org,2003/ODDB::Substance 
        oid: 6155
        descriptions: !oddb.org,2003/ODDB::SimpleLanguage::Descriptions 
          de: Paroxetin
          fr: Paroxetine
          lt: Paroxetinum
          en: Paroxetine
        synonyms: []

        effective_form: *id005
        swissmedic_code: 
      auc_factor: "5"
    sertralinum: !oddb.org,2003/ODDB::CyP450InhibitorConnection 
      oid: 105
      cyp450: *id002
      category: ""
      links: 
      - !oddb.org,2003/ODDB::Interaction::AbstractLink 
        info: The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
        href: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9284850&dopt=Abstract
        text: Clin Pharmacol Ther. 1997 Aug;62(2):145-56.
      substance: &id044 !oddb.org,2003/ODDB::Substance 
        oid: 6159
        descriptions: !oddb.org,2003/ODDB::SimpleLanguage::Descriptions 
          fr: Sertraline
          de: Sertralin
          lt: Sertralinum
          en: Sertraline
        synonyms: []

        effective_form: *id044
        swissmedic_code: 
      auc_factor: "1.25"
category: 
links: []

substance: *id044
auc_factor: 
